Peter Kosa

Peter Kosa has a diverse work experience in the field of business development and strategic alliances in the biotechnology and healthcare industry. Peter currently holds the position of Chief Business Officer at Akamis Bio, starting in June 2023. Prior to this, Peter served as the Managing Director at Myeloma Investment Fund from March 2019 to May 2023. Peter also worked as the Senior Director of Business Development at bluebird bio from May 2014 to June 2018, and as the Director of Strategic Alliances, Oncology at Novartis from May 2010 to March 2014. Before that, they held the position of Director of Business Development at Xoma from August 2008 to May 2010, and as the Deputy Director of Global Business Development and Licensing at Bayer Healthcare from January 2006 to July 2008. Peter started their career as a Life Science Advisor at CT Innovations from July 2003 to December 2005. Peter also gained valuable experience as a Postdoctoral Fellow at Harvard University from February 1998 to July 2001.

Peter Kosa has a strong educational background. Peter started their academic journey at Swarthmore College, where they pursued their undergraduate studies. The specific degree they obtained during this period is not provided. After graduating from Swarthmore College in 1991, Peter went on to attend Yale University, where they focused on Molecular Biophysics & Biochemistry. Peter completed their Ph.D. in this field in 1998. Following their doctoral studies, Peter furthered their education at the prestigious MIT Sloan School of Management. From 2001 to 2003, they pursued an MBA degree. It is worth noting that Peter also has a connection to Harvard Medical School, although the exact details regarding their degree or field of study from that institution are not provided.